Chemours CC Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.38B+1.0% | $1.33B-2.2% | $1.5B-0.9% | $1.62B+3.9% | $1.37B+0.4% | ||
| $1.17B+3.3% | $1.17B+7.3% | $1.26B+3.3% | $1.34B+7.3% | $1.13B+5.0% | ||
| $212M-10.2% | $155M-41.5% | $233M-18.5% | $278M-9.7% | $236M-16.9% | ||
| 15.4%-1.9pp | 11.7%-7.8pp | 15.6%-3.4pp | 17.2%-2.6pp | 17.3%-3.6pp | ||
| $26M-3.7% | $27M+3.8% | $26M-10.3% | $28M+7.7% | $27M-3.6% | ||
| $147M+19.5% | $130M-23.5% | $122M-10.9% | $424M+175% | $123M-10.2% | ||
| $79M-10.2% | $81M+9.5% | $80M+9.6% | $91M+23.0% | $88M+23.9% | ||
| $186M+1.6% | $161M-21.1% | $152M-43.1% | $470M+157% | $183M+8.3% | ||
| $69M+4.5% | $68M+1.5% | $68M0.0% | $67M+1.5% | $66M+4.8% | ||
| $22M+340% | $3M— | $16M+167% | $2M+300% | $5M0.0% | ||
| $8M0.0% | $8M-11.1% | $9M-18.2% | $9M-18.2% | $8M-38.5% | ||
| -$9M— | —— | —— | —— | $0+100% | ||
| -$22M— | -$67M-6,800% | $38M+219% | -$248M-459% | $0-100% | ||
| $7M+40.0% | —— | -$8M— | $131M+1,356% | $5M-68.8% | ||
| -$29M-480% | -$47M-327% | $46M+244% | -$380M-733% | -$5M-109% | ||
| -2.1%-1.7pp | -3.5%-2.7pp | 3.1%+5.2pp | -23.5%-27.4pp | -0.4%-4.3pp | ||
| -$0.19-533% | -$0.31-287% | $0.31+241% | -$2.53-749% | -$0.03-108% | ||
| -$0.19-533% | -$0.31-287% | $0.31+241% | -$2.53-732% | -$0.03-108% | ||
| $3M0.0% | $2M-33.3% | $3M0.0% | $3M0.0% | $3M0.0% | ||
| $27M+3.8% | $5M— | $2M-95.8% | $0— | $26M-40.9% | ||
| -$11M+21.4% | —— | —— | $111M+840% | -$14M— | ||
| —— | —— | $7M— | —— | $1M-66.7% | ||
| $6M-14.3% | —— | $7M-36.4% | $9M0.0% | $7M-36.4% | ||
| -$19M+66.7% | -$37M— | -$5M+81.5% | -$27M+32.5% | -$57M-5.6% | ||
| -$44M+48.8% | -$43M+59.8% | -$35M+53.3% | -$42M+40.0% | -$86M+14.9% | ||
| -$44M+60.7% | $137M— | $146M— | $93M+115% | -$112M+61.4% | ||
| $22M+340% | $3M— | $16M+167% | $2M+300% | $5M0.0% | ||
| -$14M-138% | —— | $5M— | —— | $37M+436% | ||
| $10M— | $3M-66.7% | —— | —— | —— | ||
| $49M-41.7% | $45M-58.7% | $41M-46.1% | $43M-41.1% | $84M-17.6% | ||
| $7M— | —— | $6M— | —— | —— | ||
| $13M-60.6% | $4M-50.0% | $4M-91.1% | $18M+500% | $33M+725% | ||
| $1.38B+1.0% | $1.33B-2.2% | $1.5B-0.9% | $1.62B+3.9% | $1.37B+0.4% | ||
| $47M-28.8% | $1M-98.5% | $106M+194% | -$181M-234% | $66M-50.4% | ||
| $126M-18.2% | $82M-42.3% | $186M+70.6% | -$90M-143% | $154M-24.5% | ||
| $126M-18.2% | $82M-42.3% | $186M+70.6% | -$90M-143% | $154M-24.5% | ||
| 9.1%-2.1pp | 6.2%-4.3pp | 12.4%+5.2pp | -5.6%-19.0pp | 11.3%-3.7pp | ||
| $47M-28.8% | $1M-98.5% | $106M+194% | -$181M-234% | $66M-50.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Chemours's revenue?
- Chemours (CC) generated $5.8B in revenue over the trailing twelve months, up 0.5% year over year.
- Is Chemours profitable?
- Chemours is not currently profitable: it reported a net loss of $410.0M over the trailing twelve months, a -7.0% net margin.
- What is Chemours's earnings per share?
- Chemours's diluted EPS over the trailing twelve months is $-2.72.
- Where does Chemours's income statement data come from?
- Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
